TY - JOUR
T1 - Expanding the clinical spectrum associated with GLIS3 mutations
AU - Dimitri, P.
AU - Habeb, A. M.
AU - Garbuz, F.
AU - Millward, A.
AU - Wallis, S.
AU - Moussa, K.
AU - Akcay, T.
AU - Taha, D.
AU - Hogue, J.
AU - Slavotinek, A.
AU - Wales, J. K.H.
AU - Shetty, A.
AU - Hawkes, D.
AU - Hattersley, A. T.
AU - Ellard, S.
AU - De Franco, E.
N1 - Publisher Copyright:
Copyright © 2015 by the Endocrine Society.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Context:GLIS3(GLI-similar3)isamemberoftheGLI-similarzincfingerproteinfamilyencodingforanuclear protein with 5 C2H2-type zinc finger domains. The protein is expressed early in embryogenesis and plays a critical role as both a repressor and activator of transcription. Human GLIS3 mutations are extremely rare. Objective: The purpose of this article was determine the phenotypic presentation of 12 patients with a variety of GLIS3 mutations. Methods: GLIS3 gene mutations were sought by PCR amplification and sequence analysis of exons 1 to 11. Clinical information was provided by the referring clinicians and subsequently using a questionnaire circulated to gain further information. Results: We report the first case of a patient with a compound heterozygous mutation in GLIS3 who did not present with congenital hypothyroidism. All patients presented with neonatal diabetes with a range of insulin sensitivities. Thyroid disease variedamongpatients. Hepatic and renal disease wascommonwith liver dysfunction ranging from hepatitis to cirrhosis; cystic dysplasia was the most common renal manifestation. Wedescribe new presenting features in patients with GLIS3 mutations, including craniosynostosis, hiatus hernia, atrial septal defect, splenic cyst, and choanal atresia and confirm further cases with sensorineural deafness and exocrine pancreatic insufficiency. Conclusion: We report new findings within the GLIS3 phenotype, further extending the spectrum of abnormalitiesassociatedwithGLIS3mutationsandprovidingnovelinsights intotheroleofGLIS3inhuman physiologicaldevelopment.Allbut2ofthepatientswithinourcohortarestill alive,andwedescribethefirst patient to live to adulthood with a GLIS3 mutation, suggesting that even patients with a severe GLIS3 phenotype may have a longer life expectancy than originally described.
AB - Context:GLIS3(GLI-similar3)isamemberoftheGLI-similarzincfingerproteinfamilyencodingforanuclear protein with 5 C2H2-type zinc finger domains. The protein is expressed early in embryogenesis and plays a critical role as both a repressor and activator of transcription. Human GLIS3 mutations are extremely rare. Objective: The purpose of this article was determine the phenotypic presentation of 12 patients with a variety of GLIS3 mutations. Methods: GLIS3 gene mutations were sought by PCR amplification and sequence analysis of exons 1 to 11. Clinical information was provided by the referring clinicians and subsequently using a questionnaire circulated to gain further information. Results: We report the first case of a patient with a compound heterozygous mutation in GLIS3 who did not present with congenital hypothyroidism. All patients presented with neonatal diabetes with a range of insulin sensitivities. Thyroid disease variedamongpatients. Hepatic and renal disease wascommonwith liver dysfunction ranging from hepatitis to cirrhosis; cystic dysplasia was the most common renal manifestation. Wedescribe new presenting features in patients with GLIS3 mutations, including craniosynostosis, hiatus hernia, atrial septal defect, splenic cyst, and choanal atresia and confirm further cases with sensorineural deafness and exocrine pancreatic insufficiency. Conclusion: We report new findings within the GLIS3 phenotype, further extending the spectrum of abnormalitiesassociatedwithGLIS3mutationsandprovidingnovelinsights intotheroleofGLIS3inhuman physiologicaldevelopment.Allbut2ofthepatientswithinourcohortarestill alive,andwedescribethefirst patient to live to adulthood with a GLIS3 mutation, suggesting that even patients with a severe GLIS3 phenotype may have a longer life expectancy than originally described.
UR - http://www.scopus.com/inward/record.url?scp=84943745552&partnerID=8YFLogxK
U2 - 10.1210/jc.2015-1827
DO - 10.1210/jc.2015-1827
M3 - Article
C2 - 26259131
AN - SCOPUS:84943745552
VL - 100
SP - E1362-E1369
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 10
ER -